• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于2019新型冠状病毒的当前研究方向、概念及观点(综述)

Current directions, conceptions and viewpoints on 2019-nCoV (Review).

作者信息

Feng Xiao, Xie Xiaoyu, Song Shouyang, Chen Wenjun, Bian Hongjun, Rui Fajuan, Zhu Qiang, Ren Wanhua, Qin Chengyong, Qi Jianni

机构信息

Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China.

Department of Gastroenterology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, P.R. China.

出版信息

Exp Ther Med. 2021 Jan;21(1):70. doi: 10.3892/etm.2020.9502. Epub 2020 Nov 25.

DOI:10.3892/etm.2020.9502
PMID:33365070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7716651/
Abstract

On December 31, 2019, the first case of a novel coronavirus infection was reported in Wuhan, China. The ongoing outbreak of the 2019 novel coronavirus (2019-nCoV) has caused immense global concern. According to the recommendations of the International Health Regulations Emergency Committee and the facts and cases that 215 other countries have also reported to date, the World Health Organization Director-General announced that the outbreak of 2019-nCoV constitutes a public health emergency of international concern and a severe threat to the human health worldwide. To date, the prevalence of the virus has continued in waves and is increasing globally. The present review briefly introduces the epidemiology of 2019-nCoV, as well as viral structural characteristics, and receptors and cells that may act after entering the body, laboratory examinations, imaging and pathological features, clinical manifestations, complications, treatment and management.

摘要

2019年12月31日,中国武汉报告了首例新型冠状病毒感染病例。2019新型冠状病毒(2019-nCoV)的持续爆发引起了全球的广泛关注。根据《国际卫生条例》突发事件委员会的建议以及迄今其他215个国家也已报告的事实和病例,世界卫生组织总干事宣布,2019-nCoV的爆发构成国际关注的突发公共卫生事件,对全球人类健康构成严重威胁。迄今为止,该病毒的流行呈波浪式持续,且在全球范围内不断增加。本综述简要介绍了2019-nCoV的流行病学、病毒结构特征、进入人体后可能起作用的受体和细胞、实验室检查、影像学和病理学特征、临床表现、并发症、治疗和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ef/7716651/4d575f4752b4/etm-21-01-09502-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ef/7716651/4d575f4752b4/etm-21-01-09502-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ef/7716651/4d575f4752b4/etm-21-01-09502-g00.jpg

相似文献

1
Current directions, conceptions and viewpoints on 2019-nCoV (Review).关于2019新型冠状病毒的当前研究方向、概念及观点(综述)
Exp Ther Med. 2021 Jan;21(1):70. doi: 10.3892/etm.2020.9502. Epub 2020 Nov 25.
2
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.新型冠状病毒 2019-nCoV:流行情况、与 SARS-CoV 和 MERS-CoV 的生物学和临床特征比较。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. doi: 10.26355/eurrev_202002_20379.
3
2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies.中国武汉的2019新型冠状病毒肺炎:新出现的攻击方式及应对策略
Clin Transl Med. 2020 Feb 20;9(1):19. doi: 10.1186/s40169-020-00271-z.
4
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge.2019 新型冠状病毒(2019-nCoV)爆发:新的挑战。
J Glob Antimicrob Resist. 2020 Jun;21:22-27. doi: 10.1016/j.jgar.2020.02.021. Epub 2020 Mar 7.
5
Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.新型冠状病毒(2019-nCoV)感染孕妇的母婴潜在结局:来自 SARS、MERS 和其他人类冠状病毒感染的教训。
Viruses. 2020 Feb 10;12(2):194. doi: 10.3390/v12020194.
6
WHO International Health Regulations Emergency Committee for the COVID-19 outbreak.世界卫生组织 COVID-19 疫情国际卫生条例突发事件委员会。
Epidemiol Health. 2020;42:e2020013. doi: 10.4178/epih.e2020013. Epub 2020 Mar 19.
7
The Novel Coronavirus: A Bird's Eye View.新型冠状病毒:概览
Int J Occup Environ Med. 2020 Apr;11(2):65-71. doi: 10.15171/ijoem.2020.1921. Epub 2020 Feb 5.
8
Detection and analysis of nucleic acid in various biological samples of COVID-19 patients.检测和分析 COVID-19 患者各种生物样本中的核酸。
Travel Med Infect Dis. 2020 Sep-Oct;37:101673. doi: 10.1016/j.tmaid.2020.101673. Epub 2020 Apr 18.
9
2019-nCoV - Towards a 4th generation vaccine.2019新型冠状病毒——迈向第四代疫苗
Bioinformation. 2020 Feb 12;16(2):139-144. doi: 10.6026/97320630016139. eCollection 2020.
10
Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations.2020年中国武汉新型冠状病毒爆发:强化监测对于预防新地点的持续传播至关重要。
J Clin Med. 2020 Feb 11;9(2):498. doi: 10.3390/jcm9020498.

本文引用的文献

1
Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.关于 SARS-CoV-2 病毒的治疗方法和新兴疗法的最新进展。
Eur J Pharmacol. 2020 Sep 15;883:173348. doi: 10.1016/j.ejphar.2020.173348. Epub 2020 Jul 4.
2
Impact of sex and gender on COVID-19 outcomes in Europe.欧洲 COVID-19 结局的性别差异。
Biol Sex Differ. 2020 May 25;11(1):29. doi: 10.1186/s13293-020-00304-9.
3
Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D.
性别特异性 SARS-CoV-2 死亡率:激素调节 ACE2 表达、静脉血栓栓塞和维生素 D 缺乏症风险。
Int J Mol Sci. 2020 Apr 22;21(8):2948. doi: 10.3390/ijms21082948.
4
SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens.SARS-CoV-2 可在尿液、血液、肛拭子和咽拭子标本中检测到。
J Med Virol. 2020 Sep;92(9):1676-1680. doi: 10.1002/jmv.25936. Epub 2020 Apr 30.
5
Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease.通过靶向宿主特异性 SARS-CoV-2 结构保守的主要蛋白酶发现潜在的多靶标定向配体。
J Biomol Struct Dyn. 2021 Jun;39(9):3099-3114. doi: 10.1080/07391102.2020.1760137. Epub 2020 May 5.
6
Increased expression of CD8 marker on T-cells in COVID-19 patients.COVID-19 患者 T 细胞上 CD8 标志物表达增加。
Blood Cells Mol Dis. 2020 Jul;83:102437. doi: 10.1016/j.bcmd.2020.102437. Epub 2020 Apr 13.
7
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings.氯喹和羟氯喹在非洲预防或治疗 COVID-19:医疗环境中不适当的超说明书使用需谨慎。
Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188. doi: 10.4269/ajtmh.20-0290.
8
Hispidin and Lepidine E: Two Natural Compounds and Folic Acid as Potential Inhibitors of 2019-novel Coronavirus Main Protease (2019- nCoVM), Molecular Docking and SAR Study.希匹丁和莱皮丁 E:两种天然化合物和叶酸作为 2019 年新型冠状病毒主蛋白酶(2019-nCoVM)的潜在抑制剂:分子对接和 SAR 研究。
Curr Comput Aided Drug Des. 2021;17(3):469-479. doi: 10.2174/1573409916666200422075440.
9
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19.双嘧达莫对重症 COVID-19 患者的潜在治疗作用。
Acta Pharm Sin B. 2020 Jul;10(7):1205-1215. doi: 10.1016/j.apsb.2020.04.008. Epub 2020 Apr 20.
10
Comment on 'Cutaneous manifestations in COVID-19: a first perspective' by Recalcati S.对雷卡尔卡蒂·S所著《2019冠状病毒病的皮肤表现:初步观点》的评论
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e299-e300. doi: 10.1111/jdv.16519.